(Q39125279)

9 September 2017

title

Enhanced 5-fluorouracil cytotoxicity in high COX-2 expressing hepatocellular carcinoma cells by wogonin via the PI3K/Akt pathway (English)

1 reference

9 September 2017

0 references

hepatocellular carcinoma

1 reference

1 reference

1 reference

8

Qing-Long Guo

1 reference

9 September 2017

Li Zhao

1

1 reference

9 September 2017

Yun-Ying Sha

2

1 reference

9 September 2017

Qing Zhao

3

1 reference

9 September 2017

Jing Yao

4

1 reference

9 September 2017

Bin-Bin Zhu

5

1 reference

9 September 2017

Zhi-Jian Lu

6

1 reference

9 September 2017

Qi-Dong You

7

1 reference

9 September 2017

publication date

14 February 2013

1 reference

Biochemistry and Cell Biology

9 September 2017

published in

1 reference

9 September 2017

volume

91

1 reference

9 September 2017

issue

4

1 reference

9 September 2017

page(s)

221-229

1 reference

Cyclooxygenase-2 (COX-2)--a therapeutic target in liver cancer?

9 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1139%2FBCB-2012-0077

Induction of cyclooxygenase-2 overexpression in human gastric epithelial cells by Helicobacter pylori involves TLR2/TLR9 and c-Src-dependent nuclear factor-kappaB activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FBCB-2012-0077

Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FBCB-2012-0077

Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FBCB-2012-0077

Wogonin sensitizes resistant malignant cells to TNFalpha- and TRAIL-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FBCB-2012-0077

21 January 2018

Signaling to NF-kappaB

1 reference

https://api.crossref.org/works/10.1139%2FBCB-2012-0077

Treatment of hepatocellular carcinoma using arterial chemoembolization with degradable starch microspheres and continuous arterial infusion of 5-fluorouracil

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FBCB-2012-0077

Anti-hepatocarcinoma effects of 5-fluorouracil encapsulated by galactosylceramide liposomes in vivo and in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FBCB-2012-0077

Cyclooxygenase-2 inhibition induces apoptosis signaling via death receptors and mitochondria in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FBCB-2012-0077

Down-regulation of the tumor suppressor PTEN by the tumor necrosis factor-alpha/nuclear factor-kappaB (NF-kappaB)-inducing kinase/NF-kappaB pathway is linked to a default IkappaB-alpha autoregulatory loop.

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FBCB-2012-0077

Successful treatment of advanced hepatocellular carcinoma by combined administration of 5-fluorouracil and pegylated interferon-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FBCB-2012-0077

Reactive oxygen species up-regulate p53 and Puma; a possible mechanism for apoptosis during combined treatment with TRAIL and wogonin

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FBCB-2012-0077

Overexpression of cyclooxygenase-2 in human HepG2, Bel-7402 and SMMC-7721 hepatoma cell lines and mechanism of cyclooxygenase-2 selective inhibitor celecoxib-induced cell growth inhibition and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FBCB-2012-0077

Treatment options in hepatocellular carcinoma today.

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FBCB-2012-0077

Cyclooxygenase-2 expression inhibits trophic withdrawal apoptosis in nerve growth factor-differentiated PC12 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FBCB-2012-0077

Small molecule inhibition of phosphatidylinositol-3,4,5-triphosphate (PIP3) binding to pleckstrin homology domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FBCB-2012-0077

Choline kinase down-regulation increases the effect of 5-fluorouracil in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FBCB-2012-0077

Promoter hypermethylation silences cyclooxygenase-2 (Cox-2) and regulates growth of human hepatocellular carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FBCB-2012-0077

Combination therapy of intraarterial 5-fluorouracil and systemic interferon-alpha for advanced hepatocellular carcinoma with portal venous invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FBCB-2012-0077

Reconstitution of the mammalian PI3K/PTEN/Akt pathway in yeast

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FBCB-2012-0077

Chloroquine potentiates the anti-cancer effect of 5-fluorouracil on colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FBCB-2012-0077

Down-regulation of PKHD1 induces cell apoptosis through PI3K and NF-κB pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FBCB-2012-0077

Anti-cancer natural products isolated from chinese medicinal herbs

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FBCB-2012-0077

Cyclooxygenase-2 modulates cellular growth and promotes tumorigenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FBCB-2012-0077

Cyclooxygenase-2 in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FBCB-2012-0077

Rare sugar D-allose enhances anti-tumor effect of 5-fluorouracil on the human hepatocellular carcinoma cell line HuH-7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FBCB-2012-0077

Retrospective comparison between a regular and a split-dose protocol of 5-fluorouracil, cisplatin, and mitoxantrone for the treatment of far advanced hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FBCB-2012-0077

21 January 2018

Identifiers

DOI

10.1139/BCB-2012-0077

1 reference

9 September 2017

1 reference